<html><head><style type="text/css"><!-- DIV {margin:0px;} --></style></head><body><div style="font-family:Courier New, courier, monaco, monospace, sans-serif;font-size:8pt"><DIV>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><FONT face=Calibri><FONT size=2><SPAN style="mso-ansi-language: EN-US" lang=EN-US>25 April 2010</SPAN></FONT></FONT></P>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><FONT face=Calibri><FONT size=2><SPAN style="mso-ansi-language: EN-US" lang=EN-US>Dear all,</SPAN></FONT></FONT></P>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><FONT face=Calibri><FONT size=2><SPAN style="mso-ansi-language: EN-US" lang=EN-US>I thank also for the interesting e-mails sent.</SPAN></FONT></FONT></P>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><FONT face=Calibri><FONT size=2><SPAN style="mso-ansi-language: EN-US" lang=EN-US>I´m fully agree with the position of Dr. </SPAN><B style="mso-bidi-font-weight: normal"><U><SPAN style="mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: PT-BR" lang=EN-US>Prof. Dr. Moazzem Hossain (Bangladesh)</SPAN></U></B><SPAN style="mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: PT-BR" lang=EN-US>. </SPAN></FONT></FONT></P>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><FONT face=Calibri><SPAN style="mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: PT-BR" lang=EN-US></SPAN><SPAN style="mso-ansi-language: EN-US" lang=EN-US><FONT size=2>We must focus our scientific knowledge and technical experience, no to semantic or cultural or etymological discussions on specific regional well-kown terms, instead, to look for more solutions for the <B style="mso-bidi-font-weight: normal">control, and specially fast and efficient diagnosis for the early treatment of Leishmaniasis</B>. </FONT></SPAN></FONT></P>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><FONT face=Calibri><SPAN style="mso-ansi-language: EN-US" lang=EN-US><FONT size=2>Thus, we will be able to give our contribution to rescue these diseases from the group of <B style="mso-bidi-font-weight: normal">neglected diseases</B>. <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></FONT></SPAN></FONT></P>
<P style="MARGIN: 6pt 0cm" class=MsoNormal><SPAN style="mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri><FONT size=2>Very truly yours,</FONT></FONT></SPAN></P><BR> </DIV>
<DIV align=center><FONT color=#00007f face="arial black"><STRONG>Marco Tulio A. García-Zapata, MD, PhD <BR></STRONG></FONT><FONT color=#00007f><STRONG>Physician, Full Professor & Principal Researcher in Tropical Medicine<BR></STRONG></FONT><FONT size=1 face="times new roman"><STRONG>Tropical Medicine & Dermatology Deparment (DMTD)</STRONG></FONT></DIV>
<DIV align=center><FONT size=1 face="times new roman"><STRONG>Research Nucleus on (Re)Emergents Diseases Agents (NUPEREME)</STRONG></FONT></DIV>
<DIV align=center><STRONG><FONT size=1 face="Times New Roman">International & Travel Medicine Center (USCREMIVI)</FONT></STRONG></DIV>
<DIV align=center><FONT face="arial narrow"><STRONG><FONT size=1>Tropical Pathology & Public Healt Institute (IPTSP) / Federal University of Goias (UFG)</FONT></STRONG></FONT></DIV>
<DIV align=center><FONT face="times new roman"><FONT face=Arial><FONT size=1>Caixa Postal 12911 - Setor Leste Vila Nova - 74643-970 - Goiania-GO, BRAZIL <BR></FONT></FONT></FONT><FONT size=1><STRONG><U>Phones</U>:</STRONG> Work (+62) 3269-8219; Fax: (+62) 3269-8219; 3521-1839 <BR><STRONG><U>E-mail</U></STRONG>: <A href="mailto:mctulian@yahoo.com.br" rel=nofollow target=_blank>mctulian@yahoo.com.br</A>; </FONT><A href="mailto:mctulian1@hotmail.com" rel=nofollow target=_blank><FONT size=1>mctulian1@hotmail.com</FONT></A><FONT size=1>; </FONT><A href="mailto:zapata@iptsp.ufg.br" rel=nofollow target=_blank><FONT size=1>zapata@iptsp.ufg.br</FONT></A><FONT size=1> </FONT></DIV>
<DIV><BR></DIV>
<DIV style="FONT-FAMILY: Courier New, courier, monaco, monospace, sans-serif; FONT-SIZE: 8pt"><BR>
<DIV style="FONT-FAMILY: times new roman, new york, times, serif; FONT-SIZE: 12pt"><FONT size=2 face=Tahoma>
<HR SIZE=1>
<B><SPAN style="FONT-WEIGHT: bold">De:</SPAN></B> Moazzem Hossain <directordcbd@gmail.com><BR><B><SPAN style="FONT-WEIGHT: bold">Para:</SPAN></B> Kaliyaperumal Karunamoorthi <k_karunamoorthi@yahoo.com><BR><B><SPAN style="FONT-WEIGHT: bold">Cc:</SPAN></B> Leish-l@lineu.icb.usp.br<BR><B><SPAN style="FONT-WEIGHT: bold">Enviadas:</SPAN></B> Sexta-feira, 23 de Abril de 2010 16:22:38<BR><B><SPAN style="FONT-WEIGHT: bold">Assunto:</SPAN></B> Re: [Leish-l] Fwd: name<BR></FONT><BR>24 April 2010
<DIV>Dear all</DIV>
<DIV>Thank you for your so many correspondences regarding a simple term Kala-azar and VL.Both the terms are synonymous, no doubt. Now we should think for their proper treatment and reduce their sufferings for poverty alleviation, not for debate for simple terms . What is the benefit of the patient with these terms? This will be benefit of the researchers financially, moving around the world and publication etc. So please think for the treatment of the patient , whatever is the name in any part of the world.</DIV>
<DIV><BR></DIV>
<DIV>Best regards</DIV>
<DIV><BR></DIV>
<DIV>Prof. Dr. Moazzem Hossain</DIV>
<DIV>Director Disease Control &<BR>Line Director CDC<BR>Directorate General of Health Services<BR>Mohakhali, Dhaka-1212, Bangladesh<BR>Phone:880-2-9880948<BR> 880-1715038551(Mobile)<BR>Fax : 880-2-9899085</DIV>
<DIV> <BR><BR>
<DIV class=gmail_quote>On Fri, Apr 23, 2010 at 3:14 PM, Kaliyaperumal Karunamoorthi <SPAN dir=ltr><<A href="mailto:k_karunamoorthi@yahoo.com" rel=nofollow target=_blank ymailto="mailto:k_karunamoorthi@yahoo.com">k_karunamoorthi@yahoo.com</A>></SPAN> wrote:<BR>
<BLOCKQUOTE style="BORDER-LEFT: #ccc 1px solid; MARGIN: 0px 0px 0px 0.8ex; PADDING-LEFT: 1ex" class=gmail_quote>
<TABLE border=0 cellSpacing=0 cellPadding=0>
<TBODY>
<TR>
<TD vAlign=top><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 12pt">
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 12pt">Dear colleagues,</SPAN> </P>
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal>I am absolutely support the comments made by Dr Shyam Sunder <SPAN><SPAN style="COLOR: #343434">Dr.Sunil Arora"</SPAN></SPAN>and Anuradha that KA and VL are synonymous in India and other parts of the world. </P>
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal>Very truly yours </P>
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal>K. Karunamoorthi </P>
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal></P>
<P></P>
<P></P>
<P></P>
<P></P></SPAN>
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 12pt"></SPAN> </P>
<P style="LINE-HEIGHT: 150%; MARGIN: 0in 0in 10pt" class=MsoNormal><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 12pt"></SPAN> <BR></P>
<DIV align=left><FONT color=#407f00 size=1 face="comic sans ms"><STRONG>K. Karunamoorthi</STRONG></FONT></DIV>
<DIV align=left><FONT color=#407f00 size=1 face="comic sans ms"><STRONG>M. Sc., M.Phil., D.P.H.M., </STRONG></FONT></DIV>
<DIV align=left><FONT color=#407f00 size=1 face="comic sans ms"><STRONG>Medical entomologist</STRONG></FONT></DIV>
<DIV align=left><FONT color=#407f00 size=1 face="comic sans ms"><STRONG>Jimma University</STRONG></FONT></DIV>
<DIV align=left><FONT color=#407f00 size=1 face="comic sans ms"><STRONG>Jimma, Ethiopia.</STRONG></FONT></DIV>
<DIV align=left><FONT color=#407f00 size=1 face="comic sans ms"><STRONG>MOBILE: +251913547847; +919786956123</STRONG></FONT></DIV><BR><BR>--- On <B>Wed, 21/4/10, Dr.Sunil Arora <I><<A href="mailto:skarora_in@yahoo.com" rel=nofollow target=_blank ymailto="mailto:skarora_in@yahoo.com">skarora_in@yahoo.com</A>></I></B> wrote:<BR>
<BLOCKQUOTE style="BORDER-LEFT: rgb(16,16,255) 2px solid; PADDING-LEFT: 5px; MARGIN-LEFT: 5px"><BR>From: Dr.Sunil Arora <<A href="mailto:skarora_in@yahoo.com" rel=nofollow target=_blank ymailto="mailto:skarora_in@yahoo.com">skarora_in@yahoo.com</A>>
<DIV class=im><BR>Subject: Re: [Leish-l] Fwd: name<BR></DIV>To: <A href="mailto:Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank ymailto="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</A>, "Anuradha Dube" <<A href="mailto:anuradhadube@gmail.com" rel=nofollow target=_blank ymailto="mailto:anuradhadube@gmail.com">anuradhadube@gmail.com</A>><BR>Date: Wednesday, 21 April, 2010, 2:53 PM
<DIV>
<DIV></DIV>
<DIV class=h5><BR><BR>
<DIV>
<TABLE border=0 cellSpacing=0 cellPadding=0>
<TBODY>
<TR>
<TD vAlign=top>I do endorse the comments of Dr Shyam Sunder and Anuradha that KA and VL are synonymous in India and elsewhere<BR><BR>dunil aroraemail: <A href="mailto:skarora_in@yahoo.com" rel=nofollow target=_blank ymailto="mailto:skarora_in@yahoo.com">skarora_in@yahoo.com</A><BR><BR>--- On <B>Tue, 4/20/10, Anuradha Dube <I><<A href="mailto:anuradhadube@gmail.com" rel=nofollow target=_blank ymailto="mailto:anuradhadube@gmail.com">anuradhadube@gmail.com</A>></I></B> wrote:<BR>
<BLOCKQUOTE style="BORDER-LEFT: rgb(16,16,255) 2px solid; PADDING-LEFT: 5px; MARGIN-LEFT: 5px"><BR>From: Anuradha Dube <<A href="mailto:anuradhadube@gmail.com" rel=nofollow target=_blank ymailto="mailto:anuradhadube@gmail.com">anuradhadube@gmail.com</A>><BR>Subject: Re: [Leish-l] Fwd: name<BR>To: <A href="mailto:Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank ymailto="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</A><BR>Date: Tuesday, April 20, 2010, 8:07 AM<BR><BR>
<DIV>I fully agree with Dr Shyam Sundar's view that VL and Kala azar are synonymous. Elaborately, to my understanding, VL is classified on the basis of <I>Leishmania</I> strains as below:
<DIV><BR></DIV>
<DIV><B><I>Leishmania donovani donovani</I> ( LDd),</B> commonly known as <U>Kala-azar </U>in India and Sudan (Africa) as <B>Anthroponotic VL. </B>A further manifestation in the form of<B> Post Kala-azar Dermal Leishmanoid (PKDL) </B>occurs in humans<B> </B>in<B> India and Sudan </B>(only?<B>) </B>is due to this strain only (LDd)</DIV>
<DIV><BR></DIV>
<DIV><B><I>Leishmania donovani chagasi</I> ( LDc)</B> commonly known as <U>calaazar</U> in South America (Brazil) and <B><I>Leishmania donovani infantum</I> (LDi)</B> commonly known as <U>Mediterranean VL</U> in Mediterranean, as <B>Zoonotic VL (</B>with dog as reservoir<B>)</B>. </DIV>
<DIV><BR></DIV>
<DIV>Anuradha</DIV>
<DIV><BR>
<DIV class=gmail_quote>On Thu, Apr 15, 2010 at 8:40 PM, Shyam Sundar <SPAN dir=ltr><<A href="http://us.mc332.mail.yahoo.com/mc/compose?to=drshyamsundar@hotmail.com" rel=nofollow target=_blank>drshyamsundar@hotmail.com</A>></SPAN> wrote:<BR>
<BLOCKQUOTE style="BORDER-LEFT: #ccc 1px solid; MARGIN: 0px 0px 0px 0.8ex; PADDING-LEFT: 1ex" class=gmail_quote>
<DIV style="PADDING-LEFT: 10px; PADDING-RIGHT: 10px; PADDING-TOP: 15px">
<DIV><STRONG><FONT color=#800080 face=Arial>It will be impossible erase kala-azar from leishmaniasis, you might try and restrict it to anthroponotic VL. It originated from the deadly black fever without treatment. Now also you do see occasional blackish discoloration. For most of us, VL and kala-azar us synonymous.</FONT></STRONG></DIV>
<DIV style="FONT: 10pt Tahoma">
<DIV><BR></DIV>
<DIV style="BACKGROUND: #f5f5f5">
<DIV><B>From:</B> <A title=chncosta@gmail.com href="http://us.mc332.mail.yahoo.com/mc/compose?to=chncosta@gmail.com" rel=nofollow target=_blank>Carlos Costa</A> </DIV>
<DIV><B>Sent:</B> Thursday, April 08, 2010 12:54 AM</DIV>
<DIV><B>To:</B> <A title=Leish-l@lineu.icb.usp.br href="http://us.mc332.mail.yahoo.com/mc/compose?to=Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank>Leish-L</A> </DIV>
<DIV><B>Subject:</B> [Leish-l] Fwd: name</DIV></DIV></DIV>
<DIV>
<DIV></DIV>
<DIV>
<DIV><BR></DIV><BR><BR>
<DIV class=gmail_quote>---------- Forwarded message ----------<BR>From: <B class=gmail_sendername>Ashford, R</B> <SPAN dir=ltr><></SPAN><BR>Date: 2010/4/6<BR>Subject: RE: [Leish-l] name<BR>To: Carlos Costa <<A href="http://us.mc332.mail.yahoo.com/mc/compose?to=chncosta@gmail.com" rel=nofollow target=_blank>chncosta@gmail.com</A>><BR><BR><BR>
<DIV>
<DIV dir=ltr><FONT color=#000000 size=2 face=Tahoma>'Visceral leishmaniasis' is correct for all versions. Personally I much prefer to restrict 'kala azar' to the anthroponotic disease in the Indian subcontinent. The epidemiology is so different from that of L. infantum infection that they deserve different names. The disease in East Africa is a problem! </FONT></DIV>
<DIV dir=ltr><FONT color=#000000 size=2 face=Tahoma></FONT> </DIV>
<DIV dir=ltr><FONT color=#000000 size=2 face=Tahoma>A serious constraint in advocacy of leish, one of the many reasons why malaria is so much better known, is the confusion over the names and the unfamiliarity of both 'leishmaniasis' and 'kala azar' in the public consciousness. Neither leish nor k-a is a household name.</FONT></DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma></FONT> </DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma>This doesn't answer your question and, fortunately, we have no 'Academy' of the English language, so there is no definitive answer. All versions are 'correct' if they are routinely used, which means they have to be explained and defined whenever they are used.</FONT></DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma></FONT> </DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma>By the way, I believe the 'kala', which means 'black' (same root as 'coal') refers not to skin colour, but to the seriousness of epidemics, as with 'black death' for whatever disease(s) (bubonic plague?) killed so many people at that time.</FONT></DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma></FONT> </DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma>Regards,</FONT></DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma></FONT> </DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma>Dick Ashford</FONT></DIV>
<DIV dir=ltr><FONT size=2 face=Tahoma></FONT> </DIV>
<DIV>
<DIV><FONT size=2 face=Tahoma>Consultant Biologist</FONT></DIV>
<DIV><FONT size=2 face=Tahoma>Richard W. Ashford DSc</FONT></DIV>
<DIV><FONT size=2 face=tahoma>142 Meols Parade</FONT></DIV>
<DIV><FONT size=2 face=tahoma>Meols</FONT></DIV>
<DIV><FONT size=2 face=tahoma>CH47 6AN</FONT></DIV>
<DIV><FONT size=2 face=tahoma>UK</FONT></DIV>
<DIV><FONT size=2 face=tahoma>Tel +44 (0)151 632 2714</FONT></DIV></DIV>
<DIV style="DIRECTION: ltr">
<HR>
<FONT size=2 face=Tahoma><B>From:</B> <A href="http://us.mc332.mail.yahoo.com/mc/compose?to=leish-l-bounces@lineu.icb.usp.br" rel=nofollow target=_blank>leish-l-bounces@lineu.icb.usp.br</A> [<A href="http://us.mc332.mail.yahoo.com/mc/compose?to=leish-l-bounces@lineu.icb.usp.br" rel=nofollow target=_blank>leish-l-bounces@lineu.icb.usp.br</A>] On Behalf Of Carlos Costa []<BR><B>Sent:</B> 23 March 2010 23:02<BR><B>To:</B> Leish-L<BR><B>Subject:</B> [Leish-l] name<BR></FONT><BR></DIV>
<DIV>
<DIV></DIV>
<DIV>
<DIV></DIV>
<DIV>
<DIV><STRONG>Visceral leishmaniasis or kala-azar? Which, when, how?</STRONG> </DIV>
<DIV> </DIV>
<DIV>Carlos.<BR clear=all><BR>-- <BR>Carlos H. N. Costa, MD, DSc.<BR>Instituto de Doenças Tropicais Natan Portella<BR>Universidade Federal do Piauí<BR>Brazil<BR>Telephone: +55 86 3221-3413<BR><BR></DIV></DIV></DIV></DIV></DIV></DIV><BR><BR clear=all><BR>-- <BR>Carlos H. N. Costa, MD, DSc.<BR>Instituto de Doenças Tropicais Natan Portella<BR>Universidade Federal do Piauí<BR>Brazil<BR>Telephone: +55 86 3221-3413<BR><BR>As informações contidas nesta mensagem são CONFIDENCIAIS, protegidas pelo sigilo legal, por direitos autorais e destinadas exclusivamente à pessoa ou organização para a qual a mensagem foi destinada.<BR>Warning: This message is meant only for the intended recipient of the transmission. It is forbidden any unauthorized use, alteration, reproduction and distribution. If you are not the correct recipient, please notify us immediately by return e-mail and delete this message from your system. <BR></DIV></DIV>
<DIV></DIV>
<HR>
<DIV>
<DIV></DIV>_______________________________________________<BR>Leish-l mailing list<BR><A href="http://us.mc332.mail.yahoo.com/mc/compose?to=Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank>Leish-l@lineu.icb.usp.br</A><BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR></DIV>
<DIV></DIV></DIV><BR>_______________________________________________<BR>Leish-l mailing list<BR><A href="http://us.mc332.mail.yahoo.com/mc/compose?to=Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank>Leish-l@lineu.icb.usp.br</A><BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR><BR></BLOCKQUOTE></DIV><BR></DIV></DIV><BR>-----Inline Attachment Follows-----<BR><BR>
<DIV>_______________________________________________<BR>Leish-l mailing list<BR><A href="http://us.mc332.mail.yahoo.com/mc/compose?to=Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank>Leish-l@lineu.icb.usp.br</A><BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR></DIV></BLOCKQUOTE></TD></TR></TBODY></TABLE><BR></DIV><BR>-----Inline Attachment Follows-----<BR><BR>
<DIV>_______________________________________________<BR>Leish-l mailing list<BR><A href="http://in.mc517.mail.yahoo.com/mc/compose?to=Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank>Leish-l@lineu.icb.usp.br</A><BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR></DIV></DIV></DIV></BLOCKQUOTE>
<P></P>
<P></P></TD></TR></TBODY></TABLE><BR><BR>_______________________________________________<BR>Leish-l mailing list<BR><A href="mailto:Leish-l@lineu.icb.usp.br" rel=nofollow target=_blank ymailto="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</A><BR><A href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel=nofollow target=_blank>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</A><BR><BR></BLOCKQUOTE></DIV><BR><BR clear=all><BR>-- <BR>Prof. Dr. Moazzem Hossain <BR>Director Disease Control &<BR>Line Director CDC<BR>Directorate General of Health Services<BR>Mohakhali, Dhaka-1212, Bangladesh<BR>Phone:880-2-9880948<BR> 880-1715038551(Mobile)<BR>Fax : 880-2-9899085<BR></DIV></DIV></DIV></div><br>
</body></html>